REGENERON PHARMACEUTICALS INC financial statements, including revenue, expenses, and profit
The total revenue of REGN for the last quarter is 79.00 B MXN, and it's 7.76% higher compared to the previous quarter. The net income of Q4 24 is 19.13 B MXN.